Association between Helicobacter pylori infection and growth outcomes in children: A meta-analysis

Chenjing Xu1, Yao Wu2, Shunfu Xu1,2

  • 1Department of Gastroenterology, Jiangsu Province Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.

Helicobacter
|January 8, 2022
PubMed

Insights

Helicobacter pylori (H. pylori) infection is linked to growth problems in children, particularly affecting height-for-age Z scores. This finding suggests H. pylori should be considered when diagnosing linear growth disorders in pediatric patients.

Area of Science:

  • Pediatric Gastroenterology
  • Infectious Diseases
  • Growth and Development

Background:

  • Conflicting study results exist regarding the association between Helicobacter pylori (H. pylori) infection and children's growth.
  • Previous research has explored the link between H. pylori and pediatric growth outcomes with varied conclusions.

Purpose of the Study:

  • To conduct a meta-analysis evaluating the association between H. pylori infection and various growth outcomes in children.
  • To synthesize existing evidence to clarify the impact of H. pylori on pediatric growth.

Main Methods:

  • A systematic search was performed across major databases (PubMed, Embase, Web of Science, Cochrane Library, Wanfang, CNKI) up to September 2019.
  • Meta-analysis utilized random-effects models to pool data, calculating Odds Ratios (ORs) and standardized mean differences (SMDs) with 95% confidence intervals (CIs).
  • Subgroup and sensitivity analyses were conducted to assess the robustness of the findings.

Main Results:

  • The meta-analysis included 29 studies with 9384 subjects.
  • H. pylori infection showed a significant association with ponderal growth disorders (OR: 2.47) and linear growth disorders (OR: 1.76).
  • A significant adverse impact was observed on children's height-for-age Z (HAZ) scores (SMD = -0.41), while other growth parameters (weight, BMI, etc.) showed no significant association.

Conclusions:

  • The evidence supports a link between H. pylori infection and impaired growth outcomes in children, primarily affecting HAZ scores.
  • Clinicians should consider H. pylori infection as a potential factor when investigating linear growth disorders in children.
Abstract

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
611
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
229
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
323
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
774
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
643
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
569